The next-generation AAV vectors are fueling gene therapy. By combining state-of-the-art knowledge of biology, directed evolution, and data science, Capsigen is engineering novel AAV capsids to address difficult-to-treat diseases. With highly diverse libraries using the most clinically relevant models, Capsigen is delivering fit-for-purpose vectors designed for tomorrow’s medicine—today. Capsigen is a leader in the engineer...
The next-generation AAV vectors are fueling gene therapy. By combining state-of-the-art knowledge of biology, directed evolution, and data science, Capsigen is engineering novel AAV capsids to address difficult-to-treat diseases. With highly diverse libraries using the most clinically relevant models, Capsigen is delivering fit-for-purpose vectors designed for tomorrow’s medicine—today. Capsigen is a leader in the engineering of AAV capsids for use in gene therapies, opening the path to permanent cures for patients suffering from intractable illness.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.